INS and Insulin resistance: In terms of cardiometabolic risk indicators, over two-thirds (n = 88) reported glycemic control outcomes, with 62.6% (n = 82) reporting blood glucose or HbA1c, while 48.8% (n = 64) reported on one or more insulin sensitivity markers [Homeostatic Model Assessment of Insulin Resistance (HOMA-IR), insulin levels, and quantitative insulin sensitivity check index (QUICKI)].